It was proven that fucoxanthin administration decreased WAT mass and serum triacylglycerols, improved insulin resistance, reduced blood pressure, decreased serum levels of adiponectin and the expression of leptin, and improved energy expenditure, β-oxidation and adipogenesis by upregulating PPARα, PGC1α, PPARγ and UCP-1. This evidence concerns the gene LEP and Insulin resistance.